By Mill Chart
Last update: Apr 17, 2024
Get insights into the top gainers and losers of Wednesday's after-hours session.
Ticker | Change | Comment |
---|---|---|
TIRX | 56.87% | TIAN RUIXIANG HOLDINGS LTD-A (NASDAQ:TIRX) rose 56.87% to $0.76 during Wednesday's after hours session. In the last 6 months the share price dropped with 48.76%. |
TRVN | 44.25% | TREVENA INC's (NASDAQ:TRVN) stock price increased by 44.25% to $0.58. The stock is trading 28.55% lower than a month ago. |
MBIO | 13.16% | MUSTANG BIO INC (NASDAQ:MBIO) showcases remarkable after-hours performance, with a 13.16% rise to $0.43 during Wednesday's after-hours trading. In the last month the share price dropped with 66.71%. |
SINT | 12.87% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares rose 12.87% to $0.04 during Wednesday's after hours session. The strong performance observed in the regular session, where NASDAQ:SINT registered a 62.88% gain, continues to drive positive movement in the after-hours session. |
GRTX | 12.75% | GALERA THERAPEUTICS INC's (NASDAQ:GRTX) stock price increased by 12.75% to $0.22. The positive market sentiment seen in today's regular session, where NASDAQ:GRTX closed with a 16.71% gain, carries over into the after-hours session. |
IZM | 12.52% | After the regular session, ICZOOM GROUP INC -CLASS A (NASDAQ:IZM) continues to impress in the after-hours session, with a 12.52% increase to $6.74. After today's drop of -88.26%, it looks like it is bouncing back during today's after hours session. |
IGC | 7.43% | IGC PHARMA INC (NYSEARCA:IGC) exhibits strong performance after hours, with shares rising 7.43% to $0.63 during Wednesday's after-hours session. Today's 20.68% gain extends further in today's after-hours session with an additional 7.43% increase. Two days ago the company had a press release: IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two. |
UAMY | 6.79% | UNITED STATES ANTIMONY CORP's (NYSEARCA:UAMY) stock price is advancing with 6.79% to a price of $0.26. The stock is trading 29.49% lower than 6 months ago. |
XELA | 5.98% | After the regular session, EXELA TECHNOLOGIES INC (NASDAQ:XELA) continues to impress in the after-hours session, with a 5.98% increase to $2.48. In the last 6 months the stock lost 22.7%. |
SXTC | 5.08% | Positive market activity for CHINA SXT PHARMACEUTICALS IN (NASDAQ:SXTC) after regular trading hours, with a 5.08% increase to $1.24 in the after-hours session on Wednesday. Following a -27.16% loss in the regular session, NASDAQ:SXTC displays significant price volatility in today's after-hours session. |
Our after hours gainers page will show you the full list.
Ticker | Change | Comment |
---|---|---|
SNGX | -13.73% | SOLIGENIX INC's (NASDAQ:SNGX) shares experienced a 13.73% decrease to $0.44 in the after-hours session. In the last month the share price dropped with 22.62%. |
MOTS | -12.85% | Today's after-hours session sees a continuation of the -34.06% decrease earlier in the day for NASDAQ:MOTS. It appears that the downward trend persists as NASDAQ:MOTS also experienced a -34.06% decline during the regular session. |
TCON | -10.92% | TRACON PHARMACEUTICALS INC's (NASDAQ:TCON) shares declined by 10.92% to $2.04 during Wednesday's after-hours session. After registering a 33.92% gain earlier today, NASDAQ:TCON is experiencing a 10.92% decline in today's after-hours session. |
ICU | -10.85% | SEASTAR MEDICAL HOLDING CORP's (NASDAQ:ICU) stock price is showing a decline of 10.85% to a price of $0.62 during the after-hours session. In the last 6 months the stock lost 30.36%. |
INVO | -9.34% | INVO BIOSCIENCE INC's (NASDAQ:INVO) stock price is declining with 9.34% to a price of $1.65. Price movements remain volatile as NASDAQ:INVO gives back 139.0% of its earlier gains in the after-hours session. |
TKC | -8.71% | TURKCELL ILETISIM HIZMET-ADR's (NYSE:TKC) shares declined by 8.71% to $5.11 during Wednesday's after-hours session. In the last 6 months the stock gained 26.15%. |
NA | -7.43% | NANO LABS LTD's (NASDAQ:NA) stock price is showing a decline of 7.43% to a price of $0.5 during the after-hours session. In the last month the stock lost 68.06%. |
TPET | -7.29% | Price volatility persists as NYSEARCA:TPET closed the regular session with a -30.31% loss, and the downward trend continues in the after-hours session. The after-hours session reflects NYSEARCA:TPET's ongoing correction after a -30.31% loss in the regular trading hours. |
EFX | -7.02% | EQUIFAX INC's (NYSE:EFX) stock price is declining with 7.02% to a price of $221.0. The company's earnings where released Yesterday. Shareholders saw the stock price going 35.27% higher is the past 6 months. |
RCON | -5.62% | RECON TECHNOLOGY LTD-CLASS A's (NASDAQ:RCON) stock price is declining with 5.62% to a price of $0.09. In the last month the share price dropped with 20.8%. |
To see the full list of after hours losers you can use our after hours losers page.
TREVENA INC
NASDAQ:TRVN (4/29/2024, 7:00:01 PM)
0.4
+0.01 (+2.3%)
Get insights into the top gainers and losers of Wednesday's after-hours session.
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies Company...
Trevena (TRVN) files prospectus for the resale of 2.78M shares of common stock by selling stockholders.
Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!
CHESTERBROOK, Pa., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (“Trevena” or the “Company”) (Nasdaq: TRVN), a biopharmaceutical company focused on...
Trevena (TRVN) announces agreements for the sale of shares and warrants, expected to generate $4M in gross proceeds.
CHESTERBROOK, Pa., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trevena Inc. (“Trevena” or the “Company”) (Nasdaq: TRVN), a biopharmaceutical company focused on the...
-- Presentation highlighted promising results of TRV045 in nonclinical models of neuropathic pain including mechanical and cold-stimulus evoked...
CHESTERBROOK, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Trevena Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and...
Trevena (TRVN) files SEC prospectus to raise $200M through offering common stock, preferred stock, debt securities, and warrants.
Company previously announced statistically significant topline TRV045 data from two proof-of-concept studies evaluating S1PR mechanism of action and CNS...